Epidermal growth factor receptor tyrosine-kinase inhibitor treatment resistance in non-small cell lung cancer: biological basis and therapeutic strategies

S Carrera, A Buque, E Azkona, U Aresti… - Clinical and …, 2014 - Springer
Lung cancer remains the leading cause of cancer-related death. Non-small cell lung cancer
(NSCLC) represents 85% of all lung cancer cases and it is classified into three major …
被引用次数：35 相关文章

Epidermal growth factor receptor tyrosine-kinase inhibitor treatment resistance in non-small cell lung cancer: biological basis and therapeutic strategies.

S Carrera, A Buque, E Azkona… - Clinical & …, 2014 - search.ebscohost.com
Lung cancer remains the leading cause of cancer-related death. Non-small cell lung cancer
(NSCLC) represents 85% of all lung cancer cases and it is classified into three major …

Epidermal growth factor receptor tyrosine-kinase inhibitor treatment resistance in non-small cell lung cancer: biological basis and therapeutic strategies

SC Revilla, AB Martínez, EA Uribelarrea… - Clinical & …, 2014 - dialnet.unirioja.es
Lung cancer remains the leading cause of cancer-related death. Non-small cell lung cancer
(NSCLC) represents 85% of all lung cancer cases and it is classified into three major …

Epidermal growth factor receptor tyrosine-kinase inhibitor treatment resistance in non-small cell lung cancer: biological basis and therapeutic strategies.

S Carrera, A Buque, E Azkona, U Aresti… - … : Official Publication of …, 2013 - europepmc.org
Lung cancer remains the leading cause of cancer-related death. Non-small cell lung cancer
(NSCLC) represents 85% of all lung cancer cases and it is classified into three major …

Epidermal growth factor receptor tyrosine-kinase inhibitor treatment resistance in non-small cell lung cancer: biological basis and therapeutic strategies

S Carrera, A Buque, E Azkona… - … publication of the …, 2014 - pubmed.ncbi.nlm.nih.gov
Lung cancer remains the leading cause of cancer-related death. Non-small cell lung cancer
(NSCLC) represents 85% of all lung cancer cases and it is classified into three major …

Epidermal growth factor receptor tyrosine-kinase inhibitor treatment resistance in non-small cell lung cancer: biological basis and therapeutic strategies

S Carrera, A Buque, E Azkona, U Aresti… - Clinical and …, 2014 - infona.pl
Lung cancer remains the leading cause of cancer-related death. Non-small cell lung cancer
(NSCLC) represents 85% of all lung cancer cases and it is classified into three major …

Epidermal growth factor receptor tyrosine-kinase inhibitor treatment resistance in nos-small cell lung cancer: biological basis and therapeutic strategies

S Carrera, A Buque, E Azkona, U Aresti… - Clin. transl. oncol …, 2014 - pesquisa.bvsalud.org
Lung cancer remains the leading cause of cancer-related death. Non-small cell lung cancer
(NSCLC) represents 85% of all lung cancer cases and it is classified into three major …

[引用][C] Epidermal growth factor receptor tyrosine-kinase inhibitor treatment resistance in non-small cell lung cancer: biological basis and therapeutic strategies

S Carrera, A Buque, E Azkona, U Aresti… - Clinical and …, 2013 - cir.nii.ac.jp
Epidermal growth factor receptor tyrosine-kinase inhibitor treatment resistance in non-small cell
lung cancer: biological basis and therapeutic strategies | CiNii Research CiNii 国立情報学 …

Epidermal growth factor receptor tyrosine-kinase inhibitor treatment resistance in nos-small cell lung cancer: biological basis and therapeutic strategies

S Carrera, A Buque, E Azkona, U Aresti… - Clin. transl. oncol …, 2014 - pesquisa.bvsalud.org
Lung cancer remains the leading cause of cancer-related death. Non-small cell lung cancer
(NSCLC) represents 85% of all lung cancer cases and it is classified into three major …